Lungpacer Medical Revenue and Competitors
Estimated Revenue & Valuation
- Lungpacer Medical's estimated annual revenue is currently $6.4M per year.
- Lungpacer Medical's estimated revenue per employee is $125,500
- Lungpacer Medical's total funding is $91.4M.
Employee Data
- Lungpacer Medical has 51 Employees.
- Lungpacer Medical grew their employee count by -37% last year.
Lungpacer Medical's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP | Reveal Email/Phone |
2 | Controller | Reveal Email/Phone |
3 | VP Operations | Reveal Email/Phone |
4 | VP Research | Reveal Email/Phone |
5 | VP Finance and Human Resources | Reveal Email/Phone |
6 | SVP Clinical Affairs | Reveal Email/Phone |
7 | Director Manufacturing | Reveal Email/Phone |
8 | Quality Director | Reveal Email/Phone |
9 | Senior Clinical Training Manager | Reveal Email/Phone |
10 | Software Engineering Manager | Reveal Email/Phone |
Lungpacer Medical Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $480.7M | 1915 | 10% | N/A | N/A |
#2 | $33.6M | 134 | 10% | $117.3M | N/A |
What Is Lungpacer Medical?
Lungpacer Medical Inc. is developing a novel therapeutic solution for preserving the integrity and strength of the diaphragm muscle in critically ill patients who require mechanical ventilation. The proprietary Lungpacer system is designed to activate the diaphragm using a temporary, minimally invasive, transvascular nerve stimulation approach that is expected to save many lives, improve surviving patient outcomes and greatly reduce hospital care costs. CAUTION: Investigational device. Not available for sale in any geography.
keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals
$91.4M
Total Funding
51
Number of Employees
$6.4M
Revenue (est)
-37%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Lungpacer Medical News
... Top Companies, Growth By Region, Trends And Forecasts By 2026Synapse Biomedical, Lungpacer Medical, Avery Biomedical Devices.
These factors are responsible and aggravate the medical and R&D ... Biomedical Devices, Inc, Lungpacer Medical Inc. The manufacturers of ...
Life-sciences companies, among them Lungpacer Medical and ABK Biomedical, secured $309 million invested, or a 23 percent share.
Lungpacer Medical said it won an expedited access pathway designation from the FDA for the diaphragm pacing system it's developing to treat ...
Other Companies in Burnaby
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $35M | 51 | 34% | N/A |
#2 | $11.7M | 52 | 27% | N/A |
#3 | $7.5M | 53 | 6% | N/A |
#4 | $8.9M | 55 | 104% | N/A |
#5 | $12.4M | 55 | -8% | N/A |